Literature DB >> 27486130

Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age.

Alexander Melamed1, Allison A Gockley1, Naima T Joseph1, Sue Yazaki Sun2, Mark A Clapp1, Donald P Goldstein3, Ross S Berkowitz3, Neil S Horowitz4.   

Abstract

OBJECTIVE: To quantify the effect of race/ethnicity on risk of complete and partial molar pregnancy.
METHODS: We conducted a cross-sectional study including women who were followed for complete or partial mole and those who had a live singleton birth in a teaching hospital in the northeastern United States between 2000 and 2013. We calculated race/ethnicity-specific risk of complete and partial mole per 10,000 live births, and used logistic regression to estimate crude and age-adjusted relative risks (RR) of complete and partial mole.
RESULTS: We identified 140 cases of complete mole, 115 cases of partial mole, and 105,942 live births. The risk of complete mole was 13 cases per 10,000 live births (95% confidence interval [CI] 11-16) and that of partial mole was 11 cases per 10,000 live births (95% CI 9-13). After age-adjustment, Asians were more likely to develop complete mole (RR 2.3 95% CI 1.4-3.8, p<0.001) but less likely to develop partial mole (RR 0.2; 95% CI 0.04-0.7, p=0.02) than whites. Blacks were significantly less likely than whites to develop partial mole (RR 0.4; 95% CI 0.2-0.8, p=0.01) but only marginally less likely to develop complete mole (RR 0.6; 95% CI 0.3-1.0, p=0.07). Hispanics were less likely than whites to develop complete mole (RR 0.4; 95% CI 0.2-0.7, p=0.002) and partial mole (RR 0.4; 95% CI 0.2-0.9, p=0.02).
CONCLUSION: Race/ethnicity is a significant risk factor for both complete and partial molar pregnancy in the northeastern United States.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Molar pregancy; Race-ethnicity

Mesh:

Year:  2016        PMID: 27486130     DOI: 10.1016/j.ygyno.2016.07.117

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

Review 1.  Advances in immunotherapy and molecular targeted therapy of gestational trophoblastic tumor: current practice and future perspectives.

Authors:  Suzhu Chen; Taiping Li; Lijuan Meng; Kangsheng Liu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

2.  Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report.

Authors:  Xiyan Mu; Rutie Yin; Danqing Wang; Liang Song; Yu Ma; Xia Zhao; Qingli Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

3.  Educational Case: Hydatidiform Molar Pregnancy.

Authors:  Anna Lepore; Richard M Conran
Journal:  Acad Pathol       Date:  2021-01-28

4.  Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.

Authors:  Melisa Lelic; Zlatan Fatusic; Ermina Iljazovic; Suada Ramic; Sergije Markovic; Selma Alicelebic
Journal:  Med Arch       Date:  2017-08

5.  Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.

Authors:  Helle Lund; Mogens Vyberg; Helle Højmark Eriksen; Anni Grove; Annette Østergaard Jensen; Lone Sunde
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.